AAVB-081

N/A

Report date: 2024/09/18 13:32:21

Base Information

Drug NameAAVB-081
Drug Alias NameAAVB-081Dual-AAVAAV8.MYO7A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV8 vector
Mechanisms of ActionMyosin VIIA Gene transference
TargetsMyosin VIIA
Therapy Area/IndicationsUsher Syndromes, 1BUsher Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAAVantgarde Bio SRL
China Registration ClassN/A

Develop Information

Active CompaniesFondazione Telethon ETSAAVantgarde Bio SRL
Inactive CompaniesN/A
Active IndicationsUsher Syndromes, 1BUsher Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A